ArticleFrontiers in oncology2022

Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer.

Yanjin Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.